Cargando…
EGLIF-CAR-T Cells Secreting PD-1 Blocking Antibodies Significantly Mediate the Elimination of Gastric Cancer
OBJECTIVE: To investigate the anti-tumor effects of programmed cell death protein 1 (PD-1) scFv-secreting EGFR-chimeric antigen receptor-modified (CAR)-T cells against gastric cancer. METHODS: Second-generation EGFR-CAR-T cells and fourth-generation PD-1 scFv-secreting EGFR-CAR-T cells were engineer...
Autores principales: | Zhou, Jing-Tao, Liu, Jiang-Hao, Song, Ting-Ting, Ma, Bo, Amidula, Nuermaimait, Bai, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520465/ https://www.ncbi.nlm.nih.gov/pubmed/33061585 http://dx.doi.org/10.2147/CMAR.S260915 |
Ejemplares similares
-
Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer
por: Chen, Cong, et al.
Publicado: (2021) -
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019) -
Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020) -
STUDIES ON THE ELIMINATION OF DYES IN THE GASTRIC AND PANCREATIC SECRETIONS, AND INFERENCES THEREFROM CONCERNING THE MECHANISMS OF SECRETION OF ACID AND BASE
por: Ingraham, Raymond C., et al.
Publicado: (1935) -
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)